Literature DB >> 8956803

Mammographic screening after the age of 65 years: early outcomes in the Nijmegen programme.

J van Dijck1, A Verbeek, J Hendriks, R Holland, M Mravunac.   

Abstract

We studied outcomes of mammographic screening in women older than 65 years. In 1975, breast cancer screening was started in Nijmegen, The Netherlands, for women aged 35-65 years. Since 1977, approximately 7700 older women have also been invited for biennial one-view mammography. This report is based on ten screening rounds from 1975 to 1994. The results of the subsequent screening rounds in the age groups 65-69 years, 70-74 years and 75 years and older were: participation rates 55%, 39% and 15%; screen-detected cancer rates 5.6%, 6.9% and 7.8%; interval cancer rates 2.0%, 1.8%, and 3.5%; and predictive values of referral 62%, 64% and 62% respectively. In all age groups, screen-detected patients had smaller tumours and a lower prevalence of axillary lymph node involvement than unscreened patients. Our conclusion is that, in women aged 65 years, and older, breast cancer can be detected at an earlier stage by mammographic screening.

Entities:  

Mesh:

Year:  1996        PMID: 8956803      PMCID: PMC2077211          DOI: 10.1038/bjc.1996.640

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Age-specific effectiveness of the Nijmegen population-based breast cancer-screening program: assessment of early indicators of screening effectiveness.

Authors:  P G Peer; R Holland; J H Hendriks; M Mravunac; A L Verbeek
Journal:  J Natl Cancer Inst       Date:  1994-03-16       Impact factor: 13.506

2.  Efficacy of mammographic screening of the elderly: a case-referent study in the Nijmegen program in The Netherlands.

Authors:  J A van Dijck; R Holland; A L Verbeek; J H Hendriks; M Mravunac
Journal:  J Natl Cancer Inst       Date:  1994-06-15       Impact factor: 13.506

3.  Annual summary of vital statistics--1992.

Authors:  M E Wegman
Journal:  Pediatrics       Date:  1993-12       Impact factor: 7.124

4.  The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers.

Authors:  J A van Dijck; A L Verbeek; J H Hendriks; R Holland
Journal:  Cancer       Date:  1993-09-15       Impact factor: 6.860

5.  Nation-wide breast cancer screening in The Netherlands: support for breast-cancer mortality reduction. National Evaluation Team for Breast Cancer Screening (NETB).

Authors:  H J De Koning; J Fracheboud; R Boer; A L Verbeek; H J Collette; J H Hendriks; B M van Ineveld; A E de Bruyn; P J van der Maas
Journal:  Int J Cancer       Date:  1995-03-16       Impact factor: 7.396

6.  The effect of comorbidity on 3-year survival of women with primary breast cancer.

Authors:  W A Satariano; D R Ragland
Journal:  Ann Intern Med       Date:  1994-01-15       Impact factor: 25.391

7.  National Health Service breast screening programme results for 1991-2.

Authors:  J Chamberlain; S M Moss; A E Kirkpatrick; M Michell; L Johns
Journal:  BMJ       Date:  1993-08-07

8.  Diagnostic outcome of repeated mammography screening.

Authors:  L G Arnesson; B Vitak; J C Månson; G Fagerberg; S Smeds
Journal:  World J Surg       Date:  1995 May-Jun       Impact factor: 3.352

9.  Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.

Authors:  H J de Koning; R Boer; P G Warmerdam; P M Beemsterboer; P J van der Maas
Journal:  J Natl Cancer Inst       Date:  1995-08-16       Impact factor: 13.506

10.  Report of the International Workshop on Screening for Breast Cancer.

Authors:  S W Fletcher; W Black; R Harris; B K Rimer; S Shapiro
Journal:  J Natl Cancer Inst       Date:  1993-10-20       Impact factor: 13.506

View more
  3 in total

1.  Extending the benefits of breast cancer screening. Still hard to know how large the benefits will really be.

Authors:  U Werneke; K McPherson
Journal:  BMJ       Date:  1998-08-08

Review 2.  Mammographic screening in older women. Is it worthwhile?

Authors:  J A van Dijck; M J Broeders; A L Verbeek
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

3.  Routine breast screening for women aged 65-69: results from evaluation of the demonstration sites.

Authors:  S M Moss; J Brown; L Garvican; D A Coleman; L E Johns; R G Blanks; G Rubin; J Oswald; A Page; A Evans; P Gamble; R Wilson; L Lee; J Liston; L Sturdy; G Sutton; G Wardman; J Patnick; R Winder
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.